Viewing Study NCT01210560


Ignite Creation Date: 2025-12-25 @ 2:14 AM
Ignite Modification Date: 2026-05-23 @ 8:19 AM
Study NCT ID: NCT01210560
Status: COMPLETED
Last Update Posted: 2018-06-14
First Post: 2010-09-21
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Dose-finding Study of New Tolvaptan Formulation in Subjects With ADPKD
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Autosomal Dominant Polycystic Kidney Disease View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Kidney Disease View
None Polycystic Kidney Disease View